Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Emergency use authorization Experimental Vaccine Apr/30/2021 46 0
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 40 46
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021 12 1
PCI-27483 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/12/2021 1 0
Avoralstat Potential treatment - pre-clinical evidence Experimental Antiviral Apr/12/2021 1 0
Antipain Potential treatment - pre-clinical evidence Natural product Antiviral Apr/12/2021 1 0
Soybean Trypsin Inhibitor Potential treatment - pre-clinical evidence Natural product Antiviral Apr/12/2021 1 0
Enoxaparin Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/12/2021 6 0
Convalescent plasma Emergency use authorization Experimental Antiviral Apr/10/2021 37 6